| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crescent Biopharma, Inc. (CBIO) has 13 insiders with recent SEC Form 4 filings, including 11 buys and 12 sells. CBIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.75M | $48.61M | - | |
| CEO | 323.5K | $5.72M | - | |
| COO | 153.7K | $2.72M | - | |
| Other | 70.0K | $1.24M | - | |
| Other | 54.2K | $958.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 8, 2023 | Johnson Bruce S | SVP &Chief Commercial Officer | Buy | 13,500 | $1.57 | $21,195.00 | +10.8% | +10.1% | -79.4% | |
| Feb 24, 2023 | Invus Public Equities, L.P.78 | 10% Owner | Buy | 100,000 | $1.70 | $170,000.00 | +1.2% | +3.0% | +71.6% | |
| Feb 23, 2023 | Invus Public Equities, L.P.78 | 10% Owner | Buy | 400,000 | $1.78 | $712,255.00 | +1.6% | +5.3% | +69.6% | |
| Feb 17, 2023 | Invus Public Equities, L.P.78 | 10% Owner | Buy | 1,515,266 | $2.00 | $3,027,928.63 | +6.9% | +4.0% | +71.3% | |
| Feb 9, 2023 | Invus Public Equities, L.P.78 | 10% Owner | Buy | 11,451 | $3.24 | $37,123.00 | +0.2% | -46.0% | +0.9% | |
| Jan 26, 2023 | Sandell Scott D55 | 10% Owner | Sell | 3,652,016 | $3.14 | $11,484,515.02 | -22.0% | -59.1% | -5.1% | |
| Jan 5, 2023 | Sandell Scott D55 | 10% Owner | Sell | 71,362 | $2.76 | $196,859.21 | -0.8% | -53.1% | +7.7% | |
| Jan 4, 2023 | Sandell Scott D55 | 10% Owner | Sell | 398,133 | $2.98 | $1,185,885.89 | -1.5% | -58.6% | +2.7% | |
| Dec 22, 2022 | Rock Edwin45 | Chief Medical Officer | Buy | 110,000 | $2.25 | $247,500.00 | +55.0% | -38.9% | +12.4% | |
| Nov 17, 2022 | Junius Daniel M | Director | Buy | 20,000 | $1.87 | $37,400.00 | +46.2% | -26.9% | -30.3% |